| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 184.30B | 178.85B | 167.18B | 162.52B | 140.94B | 131.01B |
| Gross Profit | 70.15B | 71.83B | 71.38B | 65.67B | 52.57B | 54.10B |
| EBITDA | 33.93B | 31.78B | 31.59B | 28.21B | 21.92B | 25.06B |
| Net Income | 23.17B | 21.79B | 21.40B | 23.22B | 15.25B | 18.64B |
Balance Sheet | ||||||
| Total Assets | 94.50B | 88.39B | 90.74B | 93.53B | 75.16B | 80.09B |
| Cash, Cash Equivalents and Short-Term Investments | 9.21B | 13.77B | 21.51B | 20.00B | 9.80B | 15.74B |
| Total Debt | 21.96B | 12.47B | 20.65B | 29.97B | 24.81B | 21.22B |
| Total Liabilities | 56.91B | 44.57B | 51.08B | 57.88B | 49.30B | 44.25B |
| Stockholders Equity | 37.34B | 43.56B | 39.42B | 35.34B | 25.58B | 35.48B |
Cash Flow | ||||||
| Free Cash Flow | 2.38B | 21.06B | 20.11B | 18.15B | 7.49B | 16.09B |
| Operating Cash Flow | 3.99B | 24.81B | 25.73B | 25.26B | 13.00B | 18.51B |
| Investing Cash Flow | 4.51B | 843.60M | 4.84B | -15.17B | 9.11B | 4.61B |
| Financing Cash Flow | -9.06B | -27.62B | -28.39B | -10.28B | -22.46B | -22.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹1.08T | 76.67 | ― | 0.70% | 15.34% | 14.67% | |
68 Neutral | ₹2.41T | 62.28 | ― | 0.97% | 6.25% | -8.80% | |
67 Neutral | ₹1.34T | 53.41 | ― | 1.24% | 7.21% | 8.68% | |
67 Neutral | ₹508.93B | 24.98 | ― | 0.80% | 19.18% | 43.36% | |
66 Neutral | ₹155.53B | -90.62 | ― | 0.28% | 14.55% | -20.61% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ₹205.47B | 89.83 | ― | 0.61% | 10.61% | 7.97% |